{"id":"W3024665518","doi":"10.1016/j.clgc.2020.05.004","title":"Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Genitourinary Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Takeda Canada; Eisai; Astellas Pharma; British Microcirculation Society; Merck Sharp and Dohme; Janssen Biotech; Meso Scale Diagnostics; Les Laboratories Pierre Fabre; Ipsen; Pharmacyclics; Astellas Pharma Canada; Sanofi España; Sanofi; GlaxoSmithKline Japan; Boehringer Ingelheim; Roche; Novartis; Bayer; University of Bristol; Merck; Novartis Farmacéutica; Ipsen Biopharmaceuticals; Bristol-Myers Squibb; AstraZeneca; Pfizer; Takeda Pharmaceutical Company","keywords":"Medicine; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Internal medicine; Urothelial cancer; Overall survival; Cancer; Bladder cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001672797,0.0003990756,0.001241754,0.0001161256,0.00007344216,0.00001182242,0.0003272659,0.000159275,0.00104445],"category_scores_gemma":[0.0001457208,0.0002895882,0.0007614075,0.0009445415,0.0002350062,0.00009044628,0.000159323,0.0005434301,0.00001226866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002704456,"about_ca_system_score_gemma":0.0005673624,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005113893,"about_ca_topic_score_gemma":0.001648407,"domain_scores_codex":[0.9969485,0.0001999515,0.00107271,0.0007953022,0.0005229993,0.000460583],"domain_scores_gemma":[0.9982417,0.0002001264,0.0003161116,0.0006610604,0.0002733069,0.0003077342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06616046,0.003109745,0.9146055,0.0001092441,0.001675229,0.0005235234,0.002142345,0.0005341091,0.0001722466,0.00000138699,0.0001643795,0.01080186],"study_design_scores_gemma":[0.05942725,0.01107171,0.9205159,0.0001030197,0.00310608,0.000001884656,0.00116205,0.0004156494,0.0005272859,0.000004101787,0.003344179,0.0003208851],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928056,0.001129552,0.00001744674,0.002678129,0.0007996688,0.001477553,0.0006221014,0.00002855716,0.0004413682],"genre_scores_gemma":[0.9960364,0.0005699479,0.0000681427,0.001604563,0.0008536961,0.0002929521,0.00004452934,0.00005755897,0.0004722846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01048097,"threshold_uncertainty_score":0.9999557,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08429556182043416,"score_gpt":0.4056710853970565,"score_spread":0.3213755235766224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}